Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients With Type 2 Diabetes

Clinical trial NCT01060059 · COMPLETED

Trial details

NCT number: NCT01060059
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Type 2 Diabetes Mellitus

Start date: 2010-04-01
Primary completion: 2012-05-01
Enrollment: 888

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.